Federal Grand Jury Investigating Framingham Pharmacy
A federal grand jury has begun to hand down subpoenas in its investigation of the deadly meningitis outbreak linked to a Framingham pharmacy, reports CBS Boston TV.
A federal grand jury has begun to hand down subpoenas in its investigation of the deadly meningitis outbreak linked to a Framingham pharmacy, reports CBS Boston TV.
Employees at Framingham-based New England Compounding Center are among those who have been called to testify.
It is an indication that the federal government is pursuing criminal charges against NECC and employees, who may have been negligent, reports CBS Boston TV.
NECC owner Barry Cadden took the fifth in the congressional hearing.
In a congressional report, the FDA considered New England Compounding Center to be a pharmacy in 2003. Pharmacies are regulated by the state, drug manufacturers are regulated by the FDA.
Congressman Ed Markey, who represents Framingham, is the senior member of the Energy and Commerce Committee, which has jurisdiction over the Food and Drug Administration (FDA).
The two Washington committees may create legislation to shift oversight of compounding pharmacies from states to the FDA.
Also in November, Massachusetts fired the director of its Board of Pharmacy after he failed to investigate a complaint against New England Compounding Center.
The FDA released a list of customers, who received products from NECC in Framingham on or after May 21.
***
Click here to find all of Framingham Patch’s coverage of NECC and the meningitis outbreak.
In This article
-
New England Compounding Center
697 Waverly St, Framingham, MA -
-
-
-
-
-
Congressman Edward Markey's Regional Office
411 Union Ave, Framingham, MA -
-
-
-
